Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study.

Pathological calcification generally consists of the formation of solid deposits of hydroxyapatite (calcium phosphate) in soft tissues. Supersaturation is the thermodynamic driving force for crystallization, so it is believed that higher blood levels of calcium and phosphate increase the risk of cardiovascular calcification. However several factors can promote or inhibit the natural process of pathological calcification. This cross-sectional study evaluated the relationship between physiological levels of urinary phytate and heart valve calcification in a population of elderly out subjects. A population of 188 elderly subjects (mean age: 68 years) was studied. Valve calcification was measured by echocardiography. Phytate determination was performed from a urine sample and data on blood chemistry, end-systolic volume, concomitant diseases, cardiovascular risk factors, medication usage and food were obtained. The study population was classified in three tertiles according to level of urinary phytate: low (<0.610 µM), intermediate (0.61-1.21 µM), and high (>1.21 µM). Subjects with higher levels of urinary phytate had less mitral annulus calcification and were less likely to have diabetes and hypercholesterolemia. In the multivariate analysis, age, serum phosphorous, leukocytes total count and urinary phytate excretion appeared as independent factors predictive of presence of mitral annulus calcification. There was an inverse correlation between urinary phytate content and mitral annulus calcification in our population of elderly out subjects. These results suggest that consumption of phytate-rich foods may help to prevent cardiovascular calcification evolution.

El análisis del flujo aórtico por ecocardiografía Doppler es útil en la estratificación pronóstica de los pacientes con estenosis aórtica grave con fracción de eyección normal / Systolic volume index by doppler echocardiography is an useful marker for stratification and prognostic evaluation in patients with severe aortic stenosis and preserved ejection fraction

Introducción y objetivos. El pronóstico de los pacientes con estenosis aórtica grave con bajo gradiente aórtico y fracción de eyección normal es controvertido. Nuestro estudio analiza el pronóstico de estos pacientes y su relación con el gradiente de presión y el flujo valvular aórtico. Métodos. Cohorte retrospectiva de 363 pacientes consecutivos con estenosis aórtica grave y fracción de eyección normal, dividida en cuatro grupos según índice de volumen sistólico mayor o menor que 35 ml/m2 y gradiente aórtico medio mayor o menor que 40 mmHg. Grupo I, flujo normal y gradiente elevado (n = 169; 47%); grupo II, flujo normal y bajo gradiente (n = 98; 27%); grupo III, bajo flujo y gradiente elevado (n = 54; 15%), y grupo IV, bajo flujo y bajo gradiente (n = 42; 12%). El objetivo primario es la mortalidad total. Resultados. Los factores de riesgo independientes de mortalidad son la edad (hazard ratio = 1,04; intervalo de confianza del 95%, 1,01-1,08) y la fibrilación auricular (hazard ratio = 2,21; intervalo de confianza del 95%, 1,24-3,94). El tratamiento quirúrgico se asocia a mayor supervivencia en todos los grupos (hazard ratio = 0,25; intervalo de confianza del 95%, 0,13-0,49). Los pacientes con bajo flujo presentan mayor mortalidad que los pacientes con flujo normal (el 26,6 frente al 13,6%; p = 0,004). El grupo II muestra mejor pronóstico (hazard ratio = 0,4; intervalo de confianza del 95%, 0,2-0,9). Conclusiones. Los pacientes con estenosis aórtica grave, fracción de eyección normal y bajo flujo aórtico presentan peor pronóstico. El análisis del flujo aórtico mediante ecocardiografía Doppler es útil en la estratificación de riesgo y en la toma de decisiones terapéuticas en pacientes con estenosis aórtica (AU)

Introduction and objectives. The prognosis of patients with severe aortic stenosis, low aortic gradient and preserved ejection fraction is controversial. Our study analyzed the prognosis of these patients and its relation to pressure gradient and aortic valve flow. Methods. We performed a retrospective cohort study of 363 consecutive patients with severe aortic stenosis and preserved ejection fraction, divided into 4 groups, based on the presence of a systolic volume index greater or lower than 35mL/m2 and the presence of a mean aortic gradient greater or lower than 40mmHg. Group I: normal flow, high gradient (n=169, 47%); group II: normal flow, low gradient (n=98, 27%); group III: low flow, high gradient (n=54, 15%), and group IV: low flow, low gradient (n=42, 12%). The primary endpoint was overall mortality. Results. Independent risk factors for mortality were age (hazard ratio=1.04; 95% confidence interval, 1.01-1.08) and atrial fibrillation (hazard ratio=2.21; 95% confidence interval, 1.24-3.94). Surgical treatment was associated with longer survival in all groups (hazard ratio=0.25; 95% confidence interval: 0.13-0.49). Mortality was higher in patients with low flow than in those with with normal flow (26.6% vs 13.6%; P=.004). The most favorable mean prognosis was found in group II (hazard ratio=0.4; 95% confidence interval, 0.2-0.9). Conclusions. Patients with severe aortic stenosis, normal ejection fraction and low aortic flow have a worse prognosis. Analysis of aortic flow by Doppler echocardiography is useful in risk stratification and therapeutic decision-making in patients with aortic stenosis (AU)

Systolic volume index by Doppler echocardiography is an useful marker for stratification and prognostic evaluation in patients with severe aortic stenosis and preserved ejection fraction.

INTRODUCTION AND OBJECTIVES: The prognosis of patients with severe aortic stenosis, low aortic gradient and preserved ejection fraction is controversial. Our study analyzed the prognosis of these patients and its relation to pressure gradient and aortic valve flow. METHODS: We performed a retrospective cohort study of 363 consecutive patients with severe aortic stenosis and preserved ejection fraction, divided into 4 groups, based on the presence of a systolic volume index greater or lower than 35 mL/m(2) and the presence of a mean aortic gradient greater or lower than 40 mmHg. Group I: normal flow, high gradient (n=169, 47%); group II: normal flow, low gradient (n=98, 27%); group III: low flow, high gradient (n=54, 15%), and group IV: low flow, low gradient (n=42, 12%). The primary endpoint was overall mortality. RESULTS: Independent risk factors for mortality were age (hazard ratio=1.04; 95% confidence interval, 1.01-1.08) and atrial fibrillation (hazard ratio=2.21; 95% confidence interval, 1.24-3.94). Surgical treatment was associated with longer survival in all groups (hazard ratio=0.25; 95% confidence interval: 0.13-0.49). Mortality was higher in patients with low flow than in those with with normal flow (26.6% vs 13.6%; P=.004). The most favorable mean prognosis was found in group II (hazard ratio=0.4; 95% confidence interval, 0.2-0.9). CONCLUSIONS: Patients with severe aortic stenosis, normal ejection fraction and low aortic flow have a worse prognosis. Analysis of aortic flow by Doppler echocardiography is useful in risk stratification and therapeutic decision-making in patients with aortic stenosis.

Supervivencia a medio plazo de los pacientes operados en cirugía cardiaca mayor / Mid-term survival of patients undergoing major cardiac surgery

Introducción y objetivos. La supervivencia en cirugía cardiaca es un parámetro de calidad de la cirugía realizada. Este estudio analiza la supervivencia y los factores de riesgo asociados con la mortalidad a medio plazo en la cirugía cardiaca del Hospital Universitario Son Dureta. Métodos. Desde noviembre de 2002 hasta diciembre de 2007, se intervino a 1.938 pacientes, que fueron estratificados en cuatro grupos de edad. De los 1.900 dados de alta vivos, se pudo realizar el seguimiento de 1.844 (fecha de corte, 31 de diciembre de 2008). La supervivencia se estimó mediante curvas de Kaplan-Meier y las variables asociadas con la mortalidad a medio plazo, mediante un análisis de regresión de Cox. Resultados. La mortalidad hospitalaria de los 1.938 pacientes fue del 1,96% (intervalo de confianza [IC] del 95%, 1,36-2,6%). La supervivencia acumulada a 1, 3 y 5 años fue del 98, el 94 y el 90%, respectivamente. La media del tiempo de seguimiento fue de 3,2 (0,01-6,06) años. La supervivencia de los pacientes de 70 años o más fue menor que la de los menores de dicha edad (log rank test, < 0,0001). La mortalidad observada al final del seguimiento fue del 6,5% (IC del 95%, 5,4-7,7%) y se asoció de forma independiente con la edad ≥ 70 años, el antecedente de función ventricular muy deprimida (fracción de eyección < 30%), hipertensión pulmonar severa, diabetes mellitus, anemia preoperatoria, accidente cerebrovascular postoperatorio y estancia hospitalaria. Conclusiones. Los pacientes dados de alta vivos presentaron una supervivencia excelente a medio plazo. La tasa de mortalidad varió en función de la edad y de otros factores presentes antes y después de la cirugía cardiaca (AU)

Introduction and Objectives. Evaluating patient outcomes following cardiac surgery is a means of measuring the quality of that surgery. The present study analyzes survival and the risk factors associated with mid-term mortality of patients undergoing cardiac surgery in Son Dureta University Hospital (Palma, Balearic Islands, Spain). Methods. From November 2002 thru December 2007, 1938 patients underwent interventions. Patients were stratified in 4 age groups. Of 1900 patients discharged from hospital, 1844 were followed until December 31, 2008. Following discharge, we constructed Kaplan-Meier survival curves and performed Cox regression analysis to determine which variables associated with mid-term mortality. Results. In-hospital mortality of the 1,938 patients was 1.96% (CI 95%, 1.36%-2.6%). Survival probability at 1, 3 and 5years follow-up was 98%, 94% and 90%, respectively. Mean follow-up was 3.2 (0.01-6.06) years. Patients aged ≥70years showed a lower survival rate than those aged <70 log="" rank="" test="" i=""> P<.0001). At the end of follow-up, mortality was 6.5% (CI 95%, 5.4%-7.7%). Age ≥70years, a history of severe ventricular dysfunction (ejection fraction<30 severe="" pulmonary="" hypertension="" diabetes="" mellitus="" preoperative="" anemia="" postoperative="" stroke="" and="" hospital="" stay="" were="" independently="" associated="" with="" mid-term="" mortality="">. Conclusions. Mid-term survival after discharge was highly satisfactory. Mid-term mortality varied with age and other pre- and postoperative factors (AU)

[Mid-term survival of patients undergoing major cardiac surgery]. / Supervivencia a medio plazo de los pacientes operados en cirugía cardiaca mayor.

INTRODUCTION AND OBJECTIVES: Evaluating patient outcomes following cardiac surgery is a means of measuring the quality of that surgery. The present study analyzes survival and the risk factors associated with mid-term mortality of patients undergoing cardiac surgery in Son Dureta University Hospital (Palma, Balearic Islands, Spain). METHODS: From November 2002 thru December 2007, 1938 patients underwent interventions. Patients were stratified in 4 age groups. Of 1900 patients discharged from hospital, 1844 were followed until December 31, 2008. Following discharge, we constructed Kaplan-Meier survival curves and performed Cox regression analysis to determine which variables associated with mid-term mortality. RESULTS: In-hospital mortality of the 1,938 patients was 1.96% (CI 95%, 1.36%-2.6%). Survival probability at 1, 3 and 5 years follow-up was 98%, 94% and 90%, respectively. Mean follow-up was 3.2 (0.01-6.06) years. Patients aged ≥ 70 years showed a lower survival rate than those aged <70 (log rank test, P <.0001). At the end of follow-up, mortality was 6.5% (CI 95%, 5.4%-7.7%). Age ≥ 70 years, a history of severe ventricular dysfunction (ejection fraction < 30%), severe pulmonary hypertension, diabetes mellitus, preoperative anemia, postoperative stroke, and hospital stay were independently associated with mid-term mortality. CONCLUSIONS: Mid-term survival after discharge was highly satisfactory. Mid-term mortality varied with age and other pre- and postoperative factors.

Fístula coronaria gigante entre el tronco coronario izquierdo y vena cava superior complicada de disección coronaria / Giant coronary artery fistula between the left main coronary artery and the superior vena cava complicated by coronary artery dissection

No disponible

No disponible

Phytate inhibits bovine pericardium calcification in vitro.

OBJECTIVE: The present study examined the inhibitory effects of pyrophosphate, etidronate, and phytate on bovine pericardium calcification in vitro. METHODS: Bovine pericardium was glutaraldehyde fixed and then placed in a flow chamber in the presence of a synthetic physiological fluid alone (control) or the fluid plus various concentrations of pyrophosphate, etidronate, or phytate. Following a 96-h incubation, fragments were removed and assayed for calcification by measuring calcium and phosphorus levels. RESULTS: The data indicated that both pyrophosphate and etidronate at 1 mg/l (5.75 and 4.95 microM, respectively) inhibited bovine pericardium calcification, whereas neither agent had an effect at 0.5 mg/l (2.87 and 2.47 microM, respectively). Phytate was the most potent inhibitor of calcification, and the effects of this agent were apparent at levels as low as 0.25 mg/l (0.39 microM). CONCLUSIONS: While pyrophosphate, etidronate, and phytate were all able to inhibit bovine pericardium calcification in vitro, phytate was found to be the most effective.

Cardiac papillary fibroelastoma in left ventricular apex.

Papillary fibroelastoma (PF) is a rare benign heart tumor and represents less than 10% of primary cardiac tumors. It mainly affects the cardiac valves and is often discovered during open heart surgery or autopsy. We present a case of a patient who was detected with a left ventricular apex tumor during the evaluation of the transient ischemic attack. The patient underwent surgery, and subsequently, macroscopic and microscopic examination confirmed the diagnosis of PF.

Effect of preoperative mild renal dysfunction on mortality and morbidity following valve cardiac surgery.

The objective of this study was to investigate the effect of preoperative mild renal dysfunction (RD) not requiring dialysis on mortality and morbidity after valve cardiac surgery (VCS). We studied 681 consecutive patients (2002-2006) who underwent valve cardiac surgery with or without coronary artery bypass graft (CABG). Preoperative RD was calculated with the abbreviated Modification of Diet in Renal Disease formula and was defined as a glomerular filtration rate <60 ml/min/1.73 m(2). Logistic regression analysis was used to assess the effect of preoperative renal dysfunction on operative and adverse outcomes. Two hundred and seven patients (30%) had preoperative mild RD. Patients with preoperative RD were older, had a higher rate of preoperative anaemia (43% vs. 25%, P<0.001) and more comorbidities. Patients with preoperative RD had worse outcomes with more reoperation (6.8% vs. 2.3%, P<0.001). Preoperative RD was significantly and independently associated with more red blood cell transfusions and longer hospital stay (median 9 vs. 8 days, P<0.001). Mortality was similar in both groups (3.4% vs. 2.3%, P=0.43). Preoperative mild renal dysfunction in patients undergoing cardiac valve surgery is an independent marker of postoperative morbidity.

[Axillary artery cannulation with a Dacron graft for surgery of the aortic arch and ascending aorta]. / Canulación axilar mediante prótesis de Dacron en cirugía del arco y la aorta ascendente.

Cannulation of the axillary artery is one possible means of establishing cardiopulmonary bypass during surgery of the ascending aorta and aortic arch. Use of a Dacron graft for cannulation has a number of advantages. In this article, we report our experience with this technique in seven consecutive patients in whom we performed an ascending aorta replacement. The associated procedures involved were aortic root reconstruction using David's procedure in two patients, the Bentall procedure in one, the hemi-arch technique in two, the complete arch and elephant trunk technique in one, aortic valve repair in one, and Valsalva sinus reconstruction in one. Circulatory arrest with antegrade cerebral perfusion was carried out in three cases. There was no in-hospital mortality, and there were no vascular or infectious complications related to axillary access. One patient presented with transient paresthesia of the brachial plexus. In all cases, cardiopulmonary bypass flow was adequate.

Canulación axilar mediante prótesis de Dacron en cirugía del arco y la aorta ascendente / Axillary artery cannulation with a Dacron graft for surgery of the aortic arch and ascending aorta

La canulación de las arterias axilares para instaurar la circulación extracorpórea es una alternativa en la cirugía del arco y la aorta ascendente. Su canulación mediante una prótesis de Dacron presenta ciertas ventajas. En el presente trabajo comunicamos nuestra experiencia con esta técnica en 7 pacientes consecutivos. En todos se realizó un recambio de la aorta ascendente. Se asociaron los siguientes procedimientos: reconstrucción de la raíz aórtica según técnica de David en 2 pacientes, intervención de Bentall en uno, hemiarco en dos, arco completo y trompa de elefante en uno, resuspensión de velos aórticos en uno y reconstrucción de senos de Valsalva en uno. Se realizó parada circulatoria con perfusión anterógrada en 3 casos. La mortalidad hospitalaria fue nula. No hubo complicaciones vasculares ni infecciosas del abordaje axilar. Un paciente presentó una parestesia transitoria por afección del plexo braquial. El flujo de la circulación extracorpórea fue adecuado en todos los casos

Cannulation of the axillary artery is one possible means of establishing cardiopulmonary bypass during surgery of the ascending aorta and aortic arch. Use of a Dacron graft for cannulation has a number of advantages. In this article, we report our experience with this technique in seven consecutive patients in whom we performed an ascending aorta replacement. The associated procedures involved were aortic root reconstruction using David's procedure in two patients, the Bentall procedure in one, the hemi-arch technique in two, the complete arch and elephant trunk technique in one, aortic valve repair in one, and Valsalva sinus reconstruction in one. Circulatory arrest with antegrade cerebral perfusion was carried out in three cases. There was no in-hospital mortality, and there were no vascular or infectious complications related to axillary access. One patient presented with transient paresthesia of the brachial plexus. In all cases, cardiopulmonary bypass flow was adequate

Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.

Calcification is an undesirable disorder, which frequently occurs in the heart vessels. In general, the formation of calcific vascular lesions involves complex physicochemical and molecular events. Calcification (hydroxyapatite) is initiated by injury and is progressed by promoter factors and/or the deficit of inhibitory signals. Myo-inositol hexakisphosphate (phytate, InsP6) is found in organs, tissues and fluids of all mammals and exhibits an important capacity as a crystallization inhibitor of calcium salts in urine and soft tissues. The levels found clearly depend on the dietary intake but it can also be absorbed topically. In this paper, the capacity of InsP6 as a potential inhibitor of cardiovascular calcifications was assessed in Wistar rats. Three groups were included, a control group, an InsP6 treated group (subjected to calcinosis induction by Vitamin D and nicotine and treated with standard cream with a 2% of InsP6 as potassium salt) and an InsP6 non-treated group (only subjected to calcinosis induction). All rats were fed AIN 76-A diet (a purified diet in which InsP6 is undetectable). Animals were monitorized every 12 hours. After 60 hours of calcinosis treatment, all rats of the InsP6 non-treated group died and the rest were sacrificed. Aortas and hearts were removed. A highly significant increase in the calcium content of aorta and heart tissue was observed in the InsP6 non-treated rats (21 +/- 1 mg calcium/g dry aorta tissue, 10 +/- 1 mg calcium/g dry heart tissue) when compared with controls (1.3 +/- 0.1 mg calcium/g dry aorta tissue, 0.023 +/- 0.004 mg calcium/g heart dry tissue) and InsP6 treated (0.9 +/- 0.2 mg calcium/g dry aorta tissue, 0.30 +/- 0.03 mg calcium/g dry heart tissue) animals. Only InsP6 non-treated rats displayed important mineral deposits in aorta and heart. These findings are consistent with the action of InsP6, as an inhibitor of calcification of cardiovascular system.

[Survival after recurrent left ventricular free wall rupture, with an atypical occurrence after post-infarction exercise test]. / Supervivencia a rotura cardíaca recurrente de pared libre ventricular izquierda, con presentación atípica tras ergometría postinfarto.

Left ventricular free wall rupture is an unusual but highly lethal complication of acute myocardial infarction. We report on the extremely rare occurrence of a patient surviving two episodes of free wall rupture within a seven-month period. The first event happened in the course of an exercise testing after a seemingly uncomplicated inferior acute myocardial infarction; the second, seven months after the first, as a pseudoaneurysm in the setting of a new inferior wall infarction. Surgical repair was successful in both instances, with patient remaining asymptomatic in follow-up.

Supervivencia a rotura cardíaca recurrente de pared libre ventricular izquierda, con presentación atípica tras ergometría postinfarto / Survival after Two Consecutive Left Ventricular Free Wall Ruptures, with an Atypical Occurrence after a Pre-Discharge Exercise Test

La rotura aguda de la pared libre ventricular izquierda es una complicación poco frecuente del infarto agudo de miocardio, pero que comporta una elevada mortalidad.Presentamos el caso infrecuente de un paciente que 'sobrevivió' a 2 roturas cardíacas, en ambas ocasiones con una presentación atípica: la primera durante la realización de una ergometría tras un infarto no complicado, y la segunda 7 meses después de la primera, en forma de seudoaneurisma, en el contexto de la fase hiperaguda de un nuevo infarto inferior. En ambos casos el paciente fue tratado quirúrgicamente con éxito, quedando asintomático en el seguimiento (AU)

Rotura espontánea de músculo papilar con coronarias angiográficamente normales / Spontaneous Papillary Muscle Rupture in the Absence of Coronary Artery Disease

La rotura de músculo papilar es una afección poco frecuente, normalmente secundaria a una complicación mecánica del infarto agudo de miocardio o a un traumatismo torácico. Presentamos el caso clínico de una paciente que presentó una rotura espontánea completa de músculo papilar posteromedial e insuficiencia mitral severa secundaria, por necrosis aislada del papilar, sin lesiones coronarias angiográficas, que evolucionó a shock cardiogénico, requiriendo cirugía emergente de sustitución valvular mitral, realizada con éxito. Se ha revisado la escasa bibliografía clínica e histopatológica al respecto y se comentan los posibles mecanismos de dicha rotura. (AU)

Endocarditis por Bartonella en un paciente con infección por el virus de la inmunodeficiencia humana / Endocarditis by Bartonella in a patient with human immunodeficiency virus infection

No disponible